MSKCC says senior execs may not hold industry board seats

Memorial Sloan Kettering Cancer Center has barred its senior executive officers from holding board positions at MSKCC spinouts or external for-profit health and science-related entities, according to a staff memo sent by SVP and Chief Risk Officer Debra Berns Friday.

In the memo, Berns said the new rules

Read the full 472 word article

User Sign In